Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations before the occurrence of typical pathological changes in the endomyocardial biopsies of Fabry disease patients-Reference-Cited by-同舟云学术

Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations before the occurrence of typical pathological changes in the endomyocardial biopsies of Fabry disease patients

Published:2019-01 Issue:1 Volume:21 Page:224-232
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Hsu Ming-Jia,Chang Fu-Pang,Lu Yung-Hsiu,Hung Sheng-Che,Wang Yu-Chen,Yang An-Hang,Lee Han-Jui,Sung Shih-Hsien,Wang Yen-Feng,Yu Wen-Chung,Hsu Ting-Rong,Huang Po-Hsun,Chang Sheng-Kai,Dzhagalov Ivan,Hsu Chia-Lin,Niu Dau-Ming

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

https://www.nature.com/articles/s41436-018-0010-z.pdf

Reference39 articles.

1. α-Galactosidase A deficiency: Fabry disease (2001);Desnick,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenging the Conventional Treatment Initiation Paradigm: Early Detection of Irreversible Cellular Damage in Cardiac Biopsies of Fabry Disease Before the Formation of Gb3 Inclusion Bodies;2024-07-01

2. Flow Cytometry-Based Assay to Detect Alpha Galactosidase Enzymatic Activity at the Cellular Level;Cells;2024-04-19

3. Mechanistic Insights into Dibasic Iminosugars as pH-Selective Pharmacological Chaperones to Stabilize Human α-Galactosidase;JACS Au;2024-02-23

4. Challenging the Conventional Treatment Initiation Paradigm: Early Detection of Irreversible Cellular Damage in Cardiac Biopsies of Fabry Disease Before the Formation of Gb3 Inclusion Bodies;2023-08-13

5. Investigation of bone mineral density and the changes by enzyme replacement therapy in patients with Fabry disease;Molecular Genetics and Metabolism;2023-08